Online citations, reference lists, and bibliographies.
← Back to Search

The Relevance Of The Lewy Body To The Pathogenesis Of Idiopathic Parkinson's Disease.

W. Gibb, A. Lees
Published 1988 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The Lewy body is a distinctive neuronal inclusion that is always found in the substantia nigra and other specific brain regions in Parkinson's disease. It is mainly composed of structurally altered neurofilament, and occurs wherever there is excessive loss of neurons. It occurs in some elderly individuals and rarely in other degenerative diseases of the central nervous system. In 273 brains of patients dying from disorders other than Parkinson's disease, the age-specific prevalence of Lewy bodies increased from 3.8% to 12.8% between the sixth and ninth decades. Associated pathological findings suggest that these cases of incidental Lewy body disease are presymptomatic cases of Parkinson's disease, and confirm the importance of age (time) in the evolution of the disease. In view of the common and widespread occurrence of this disorder we propose that endogenous mechanisms operating in early life may be more important than environmental agents in the pathogenesis of Lewy bodies and Parkinson's disease.
This paper references
Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?
K. Kosaka (1984)
10.1097/00005072-198305000-00120
113 WHAT IS S-100 PROTEIN?
H. M. Liu (1983)
10.1016/0022-510X(73)90175-5
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
H. Bernheimer (1973)
Lewy bodies in cerebral cortex
K. Kosaka (1978)
BaGal forebrain neurons in the dementia of Parkinson dii - ease
PJ Whitehouse (1983)
10.1002/9780470513422.CH2
Nerve cell death in degenerative diseases of the central nervous system: clinical aspects.
Y. Agid (1987)
[FAMILIAL CEREBELLAR ATROPHY WITH ASSOCIATION OF NIGERIAN AND SPINAL LESIONS].
J. Sigwald (1964)
10.1126/SCIENCE.6308771
Lewy bodies of Parkinson's disease contain neurofilament antigens.
J. Goldman (1983)
Joseph disease: a multisystem degenerative disorder of the nervous system
H S Sachdev (1982)
Ageing of the substantia nigra
S Hirai (1968)
10.1097/00005072-196507000-00003
Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's Disease
P. Duffy (1965)
10.1016/S0140-6736(83)90802-4
AETIOLOGY OF PARKINSON'S DISEASE
D. Calne (1983)
10.1212/WNL.34.10.1354
The low concordance rate for Parkinson's disease in twins
R. Eldridge (1984)
The Lewy body in the brain
S Hamada (1952)
10.1002/ANA.410130304
Basal forebrain neurons in the dementia of Parkinson disease
P. Whitehouse (1983)
10.1097/00005072-198305000-00118
111 IMMUNOCYTOCHEMICAL STAINING OF NEUROFIBRILLARY TANGLES AND OF THE PERIPHERY OF LEWY BODIES WITH A MONOCLONAL ANTIBODY TO NEUROFILAMENTS
L. Forno (1983)
Monoclonal antibodies to Alzheimer neurofibrillary tangles. 2. Demonstration of a common antigenic determinant between ANT and neurofibrillary degeneration in progressive supranuclear palsy.
D. Dickson (1985)
The Lewy body and Parkinson's disease
Wrg Gibb (1987)
10.1136/jnnp.23.1.74
THE INCIDENCE AND CHARACTERISTICS OF LEWY BODIES IN IDIOPATHIC PARALYSIS AGITANS (PARKINSON'S DISEASE)
J. Bethlem (1960)
Erkrankungen der GroBhirnrinde im Lichte der Topistik , Pathoklise und Patho - architektonik
C Vogt (1922)
Atrophie cerebelleuse familiale avec association de lesions nigeriennes et spinales
J Sigwald (1964)
Neuropathology of progressive autonomic failure
D Oppenheimer (1983)
Parkinson's disease : clinical and experimental advances
F. Rose (1987)
10.1001/ARCHNEUR.1967.00470210008002
Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells.
A. Hirano (1967)
Relationship of aging to Parkinson's disease.
W. Koller (1987)
Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus
R. Hassler (1938)
Neuropathology of the locus coeruleus: a semiquantitative study
M. Tomonaga (1983)
10.1097/00005072-196207000-00012
CONCENTRIC HYALINE INCLUSION BODY FORMATION IN MENTAL DISEASE ANALYSIS OF TWENTY‐SEVEN CASES
J. S. Woodard (1962)
idiopathic paralysis agitans (Parkinson's disease)
S. Hunter (1960)
10.1002/ANA.410200403
Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
L. Forno (1986)
10.1136/bmj.292.6519.534
Parkinson's disease in a Scottish city.
W. J. Mutch (1986)
The pathology of Parkinsonism Recent Advances in Parkinson's Disease
Ls Forno (1971)
10.1056/NEJM198508223130817
Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases.
J. Kahn (1985)
10.1017/S0317167100046345
The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
R. S. Burns (1984)
10.1001/ARCHNEUR.1982.00510220042009
Reversible drug-induced parkinsonism. Clinicopathologic study of two cases.
A. Rajput (1982)
Reversible drug-induced Parkinsonism
AH Rajput (1982)
The neurotoxicity of l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man
R S Burns (1984)
BaGal forebrain neurons in the dementia of Parkinson diiease
P J Whitehouse (1983)
The Lewy body and Parkinson ' s disease
F CliffordRose (1987)
10.1212/WNL.33.7.815
Parkinson's disease in 65 pairs of twins and in a set of quadruplets
C. D. Ward (1983)
Juvenile parkinsonism--some clinical, pharmacological, and neuropathological aspects.
M. Yokochi (1984)
Erkrankungen der GroBhirnrinde im Lichte der Topistik, Pathoklise und Pathoarchitektonik
C Vogt (1922)
Neuropathology of progressive autonomic failure
M Yokochi (1983)
Dopamine deficiency and dopamine substitution in Parkinson's disease
(1986)
10.5555/uri:pii:0016508584900799
Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.
S. Qualman (1984)
10.1001/ARCHNEUR.1986.00520080022014
Smoking and Parkinson's disease. Search for a dose-response relationship.
L. Golbe (1986)
10.1001/ARCHNEUR.1974.00490310072012
Hallervorden-Spatz syndrome.
E. Dooling (1974)
10.1097/00004714-198304000-00014
Reversible drug-induced parkinsonism: clinicopathologic study of two cases
A. Rajput (1983)
Dopamine deficiency and dopamine substitution in Parkinson's disease The Neurobiology of Dopamine Systems
Hornykiewicz (1986)
Dopamine deficiency and dopamine substitution in Parkinson ' s disease
W Winlow (1986)
10.1097/00005053-195212000-00017
Über Zelleib-verÄnderungen Im Nucleus Coeruleus Bei Parkinson-symptomen
D. Beheim-schwarzbach (1952)
10.1097/00005072-197909000-00003
ATAXIA‐TELANGIECTASIA REPORT OF A CASE WITH LEWY BODIES AND VASCULAR ABNORMALITIES WITHIN CEREBRAL TISSUE
D. Agamanolis (1979)
Ober Zelleib-veranderungen im nucleus coeruleus bei Parkinsonian-symptomen
D Beheim-Schwarzbach (1952)
The Lewy body in the brain of the aged
S Hamada (1963)
Neuropathology of progressive autonomic failure Autonomic failure
D Oppenheimer (1983)
10.1111/j.1365-2990.1989.tb01147.x
THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE
W. Gibb (1989)
[Histochemical study on the regressive degeneration of the senile brain, with special reference to the aging of the substantia nigra].
S. Hirai (1968)



This paper is referenced by
Cortical Lewy Body DeInentia
William R Gibb (2014)
10.1227/01.NEU.0000073315.88827.72
Autotransplantation of Human Carotid Body Cell Aggregates for Treatment of Parkinson’s Disease
V. Arjona (2003)
study of the growth hormone response to apomorphine. Psychotic and depressive symptoms in Parkinson's disease. A
John D C Mellers (2012)
10.4172/2161-0460.1000284
ParkinsonâÂÂs Disease (Pathogenesis and Its Management): An Overview
Naresh Korrapati (2016)
Estudio del sistema nervioso autónomo en la enfermedad de Parkinson y otras alfasinucleinopatías
Judith Navarro Otano (2014)
10.1097/NEN.0b013e31820805b9
Possible Involvement of Complement Factor C1q in the Clearance of Extracellular Neuromelanin From the Substantia Nigra in Parkinson Disease
C. Depboylu (2011)
10.1201/9780203912164.pt2
Epidemiology of Parkinsonism
A. Rajput (2003)
10.1111/ene.13691
First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire
P. Martínez-Martín (2018)
10.1136/jnnp.2006.091835
Is it Parkinson’s disease, and if not, what is it?
Kate Sophia Mary Taylor (2006)
10.1136/jnnp.63.2.228
Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson’s disease
A. Churchyard (1997)
10.1186/2047-783X-19-29
Stereopsis impairment is associated with decreased color perception and worse motor performance in Parkinson’s disease
L. Sun (2014)
10.1038/s41598-020-58042-2
Evaluating Mild Cognitive Dysfunction in Patients with Parkinson’s Disease in Clinical Practice in Taiwan
R. Yu (2020)
10.1136/jnnp.67.4.511
Unilateral pallidotomy for Parkinson’s disease: results after more than 1 year
A. Schrag (1999)
10.1111/j.1471-4159.2012.07879.x
Glucocerebrosidase Mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease
M. Kurzawa-Akanbi (2012)
10.1002/mds.10459
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
I. Litvan (2003)
10.1159/000094871
Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia
B. Mollenhauer (2006)
10.1016/j.jocn.2008.08.027
The relationship between low bone mineral density and Parkinson’s disease in a Korean population
In-Uk Song (2009)
10.1148/radiol.14131448
MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease.
M. Cosottini (2014)
10.1111/j.1600-0404.1999.tb07355.x
Twenty‐four‐hour heart rate variability to assess autonomic function in Parkinson's disease
C. Mastrocola (1999)
Impact of α-Synuclein Pathology on Aging
L. Parkkinen (2005)
10.1136/jnnp.2003.022780
Use and interpretation of on/off diaries in Parkinson’s disease
J. Reimer (2004)
10.1007/s002590050544
Peripheral sympathetic dysfunction in patients with Parkinson’s disease without autonomic failure is heart selective and disease specific
J. Taki (2000)
10.1093/ije/25.6.1301
Whooping Cough and Parkinson's Disease
J. de Pedro-Cuesta (1996)
10.1007/s00455-015-9653-y
Videofluoroscopic Predictors of Penetration–Aspiration in Parkinson’s Disease Patients
N. Argolo (2015)
10.3736/JCIM20100306
[Effects of Bushen Huoxue Granule on motor function in patients with Parkinson's disease: a multicenter, randomized, double-blind and placebo-controlled trial].
M. Yang (2010)
10.1111/ncn3.167
Zonisamide in the early stage of Parkinson's disease
T. Maeda (2015)
10.1046/j.0305-1846.2001.00342.x
α‐Synuclein pathology is highly dependent on the case selection
L. Parkkinen (2001)
10.3174/ajnr.A2837
Structural Brain Abnormalities in Patients with Parkinson Disease: A Comparative Voxel-Based Analysis Using T1-Weighted MR Imaging and Magnetization Transfer Imaging
K. Morgen (2011)
10.1016/j.ajhg.2016.02.022
Cryptic Amyloidogenic Elements in the 3' UTRs of Neurofilament Genes Trigger Axonal Neuropathy.
A. Rebelo (2016)
10.1016/j.brs.2012.12.004
Study of Cerebello-Thalamocortical Pathway by Transcranial Magnetic Stimulation in Parkinson's Disease
F. Carrillo (2013)
10.7861/CLINMEDICINE.13-1-93
How to treat Parkinson's disease in 2013.
P. Worth (2013)
10.1051/SM/2013101
Kinesthetic imagery of gait in advanced Parkinson's disease
Audrey Maillet (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar